-- Decide what to outsource based on an in-depth assessment of core competencies. -- Achieve consensus across the organization on a standardized approach to outsourcing. -- Be prepared to commit management time to administer external service providers. Short changing that effort will likely lead to an unsatisfactory experience. -- Annually review your forecast of planned studies and internal resources."Most importantly," Kaitin said, "companies need to keep in mind that one approach may not be appropriate for all development programs. Some may require a tactical approach, which is more ad hoc and project oriented, while others may benefit from a more formalized and portfolio oriented strategic approach." SCHEDULED R&D MANAGEMENT ROUNDTABLES Upcoming Tufts CSDD R&D Roundtable meetings in 2008 will focus on the following:
-- May 1 - Leveraging Metrics and Market Factors for Portfolio Decision Making -- Sept. 11 - Optimizing Protocol Design -- Strategies to Improve Clinical Research Performance -- Nov. 6 - Assessing Change and Opportunity in the Phase I LandscapeTo register, call 617-636-2170. ABOUT THE TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT The Tufts Center for the Study of Drug Development (http://csdd.tufts.edu) at Tufts University provides strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical development, review, and utilization. A core element of the center's educational efforts, the Tufts CSDD Institute for Professional Development, produces the R&D Management Roundtable series, along with postgraduate level courses, training workshops, symposia, and public forums.
Contact Information: Contact: Tufts Center for the Study of Drug Development Charlene Neu 617-636-2187 Business Communication Strategies Peter Lowy 617-734-9980